prolonged stress, however, the UPR aims toward apoptosis, including induction of C/EBP homologous protein (CHOP) proapoptotic pathways. 8, 9 To date, studies have indicated that excessive activation of ER stress/CHOP signaling is associated with various cardiovascular diseases, including atherosclerosis, vascular and valvular calcification, myocardial reperfusion injury, and heart failure. [10] [11] [12] Previous studies have demonstrated the important role of ER stress in viral infection. 13 Viruses can induce ER stress either through overwhelming protein production, or directly disrupting ER stress signaling to facilitate virus replication and pathogenesis. [14] [15] [16] Several recent studies showed that CVB3 infection could also trigger ER stress, resulting in its downstream CHOP activation and promoting apoptosis in HeLa cells and HL-1 cells. 17, 18 Thus, it seems that CVB3 infection may also induce cardiac ER stress, active CHOP, lead to cardiomyocytes apoptosis, and finally promote AVMC progression.
To test our hypothesis, we generated CVB3-induced AVMC in vivo, and investigated whether and how ER stress and CHOP-mediated pathways contributed to AVMC development using both pharmacological ER stress inhibitor tauroursodeoxycholic acid (TUDCA), 19 and genetically CHOP-deficient mice.
Methods

Ethics Statement
All experiments were approved by the Animal Care and Use Committee of Zhejiang University (zju201308-1-01-085) and meet the Guide for the Care and Use of Laboratory Animals of the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) . All efforts were made to minimize the number of animals used and their suffering.
Mice
Male CHOP −/− mice with C57BL/6 background and their littermate controls were purchased from Model Animal Research Center of Nanjing University (Nanjing, China).
Virus
The CVB3 (3 m strain), a mutant of Coxsackie virus B3 (Nancy) strain, was preserved in Institute of Hypertension and Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. CVB3 virus was maintained by passage through HeLa cells. The virus titer was determined by 50% tissue culture infectious dose (TCID 50 ) assay of HeLa cell monolayer according to Reed and Muench method. 20
Animal Grouping and Virus Inoculation
All animal protocols were approved by the Institutional Animal Care and Use Committee of Zhejiang University, China. AVMC was induced by intraperitoneal injection of 1000 TCID 50 of CVB3 virus, whereas all other groups received equal amount of vehicle (DMEM). For assaying the effect of TUDCA on AVMC, 4-week-old male C57BL/6 mice were randomly divided into 3 groups, such as control group (n=10), CVB3 group (n=11) receiving CBV3 injection, and CVB3+TUDCA group (n=11) receiving CVB3 injection supplemented with 0.5g/kg per day TUDCA by oral gavage. Animals without TUDCA treatment received equal amount of vehicle (water) by oral gavage. For determining the involvement of CHOP in AVMC, animals were randomly assigned into 3 groups, such as WT group (n=10 of 4-week-old male C57BL/6 mice), WT+CVB3 group (n=10 of 4-week-old male C57BL/6 mice) receiving CVB3 injection, and CHOP −/− +CVB3 group (n=10 of 4-week-old male CHOP −/− mice) receiving CVB3 injection. To indicate the activation of ER stress and serve as the positive control, WT mice (4-week-old male C57BL/6 mice, n=5) received subcutaneous infusion of isoproterenol (Iso, Sigma-Aldrich, St. Louis, MO, 30 μg/g per day) with mini-osmotic pumps for 14 days to induce heart failure, which were identified by both echocardiography and hemodynamic analysis.
Echocardiography and Hemodynamic Measurement
Transthoracic echocardiography was performed at day 7 after CVB3 inoculation. Mice were anesthetized by isoflurane inhalation. A comprehensive echocardiographic study was performed, including 2-dimensional imaging and M-mode imaging using the Vevo 2100 system (VisualSonics, Toronto, Canada). 21 For hemodynamic measurement, a 1.4 F pressure catheter (SPR 671, Millar Instruments) was inserted into the LV through the right common carotid artery after anesthesia. Left ventricular systolic pressure, left ventricular end diastolic pressure, left ventricular developed pressure, dP/dt max and dP/dt min were measured as described previously. 21 Subsequent data calculations were performed by operators blinded to the treatment assignment. Mice were then euthanized for further analysis.
Histopathology and Immunohistochemistry
Mice hearts were harvested and fixed in 10% phosphatebuffered formalin, then trimmed and embedded routinely in paraffin. Four micrometer sections were subsequently stained with hematoxylin and eosin. The severity of myocarditis was assessed by a previously described using 0 to 4 scale, in which 0=no inflammation; 1=1-5 distinct mononuclear inflammatory foci with involvement of 5% or less of the cross-sectional area; 2=>5 distinct mononuclear inflammatory foci, or involvement of between 5% and 20% of the cross-sectional area; 3=diffuse mononuclear inflammation involving >20% of the area, without necrosis; and 4=diffuse inflammation with necrosis. 22 Immunohistochemical staining were performed using the following antibodies: F4/80 (1:50 dilution, Santa Cruz, Santa Cruz, CA), KDEL (1:200 dilution, Santa Cruz), CHOP (1:50 dilution, Santa Cruz), and CVB3 viral protein (VP1, 1:200, Novocastra, Buffalo Grove, IL). Image-Pro Plus (Media Cybernetics, Warrendale, PA) was applied to determine quantitative results (positive staining area/total area). 23 Investigators performing the analyses were blinded to the study groups.
Determination of Serum Cardiac Troponin I
Serum cardiac troponin I (cTnI) was determined using a commercial mouse cTnI ELISA kit (Life Diagnostics, West Chester, PA), according to the manufacturer's instructions.
Quantification of Virus Titers in Mice Hearts
The CVB3 titers in hearts, liver, and pancreas were determined and expressed as TCID 50 as described previously. 24 Briefly, tissues were partially homogenized in 2-mL DMEM. After centrifugation of samples, the supernatants were sequentially 10-fold diluted, added to 96-well microtiter plates containing HeLa cells for TCID 50 determination, calculated by the method of Reed and Muench, 20 and displayed after log calibration.
Western Blot Analysis
Tissue samples were homogenized and subsequently performed for Western blot as described previously. 25 The following antibodies were applied: p-inositol-requiring enzyme 1α (1:2000 dilution) from Pierce, Rockford, IL; p-PKR-like endoplasmic reticulum kinase (1:500 dilution), activation of transcription factor 6 (1:500 dilution), CHOP (1:500 dilution), atrial natriuretic peptide (ANP, 1:500 dilution) from Santa Cruz; Bcl-2 (1:1000 dilution); and Bax (1:1000 dilution), cleaved caspase 3 (1:1000 dilution) from Cell Signaling, Danvers, MA. β-actin was used as normalization for total protein. Bands were quantified by densitometry using Quantity One Software (Bio-Rad, Hercules, CA).
Statistical Analysis
All values are presented as mean±SE. After confirming that all variables were normally distributed by the Kolmogorov-Smirnov test followed by Q-Q plots analysis, statistical differences were determined by ANOVA followed by Bonferroni multiple comparison test. Kaplan-Meier curve was applied to determine the survival data. P<0.05 was accepted as statistically significant. All statistical calculations were carried out using SPSS version 17.0 (SPSS Inc, Chicago, IL).
Results
ER Stress Is Activated in CVB3-Induced AVMC
We speculated that CVB3 replication may trigger ER stress in heart. As expected, KDEL, an ER stress marker, 11 was exclusively overexpressed in the myocardium of infected mice ( Figure 1A and 1B). In parallel with the increased expression of the heart failure marker, ANP, Western blot analysis further confirmed the induction of ER stress by assessing the activation of 3 branches of UPR, PKR-like endoplasmic reticulum kinase, inositol-requiring enzyme 1α, and activation of transcription factor 6 26 
TUDCA Administration Inhibits CVB3 Infection-Induced Cardiac ER Stress In Vivo
TUDCA is a classic chemical chaperone to alleviate ER stress by improving ER folding capacity both in vitro and in vivo. 19 We determined whether TUDCA administration could also suppress CVB3 infection-induced cardiac ER stress activation in vivo. As shown in Figure 1 , TUDCA markedly attenuated the ER stress response in hearts of CVB3-infected mice, indicating that TUDCA could effectively suppress CVB3 infection-induced cardiac ER stress activation in vivo. 
Inhibition of ER Stress Prevents CVB3-Induced Cardiomyocyte Damage, CVB3 Replication, and Cardiac Dysfunction
Previous reports indicated that inhibition of ER stress is protective against cardiac dysfunction in vivo, 27, 28 but whether it could be beneficial in CVB3-induced AVMC remains unclear. To confirm the aberrant cardiac ER stress is not secondary to CVB3 infection, we further determined whether inhibition of ER stress by TUDCA administration could attenuate CVB3 infection-induced AVMC development.
We detected that TUDCA attenuated cardiac pathological score, inflammatory cells infiltration (Figure 2 ), inflammatory cytokines mRNA expression ( Figure I Serum cTnI level is a sensitive indicator of myocardial injury, 29 we used cTnI as a marker of cardiomyocyte damage during the active proliferative phase pi. 3 Paralleled with reduced cardiac ER stress response, we found serum cTnI levels increased dramatically 7 days pi, whereas TUDCA administration significantly suppressed this effect ( Figure 3A ).
Significant left ventricular dysfunction occurs in CVB3-induced AVMC in mice. 30 We further assayed the potential of TUDCA to inhibit CVB3-mediated cardiac dysfunction. We found that TUDCA effectively prevented cardiac ANP induction and heart weight/body weight ratio increase ( Figures 1C, 1D and 3B ). Cardiac function was determined by both Millar catheter and echocardiography. As Figure 3C -3F, Tables I and II in the Data Supplement depicted, CVB3 infection led to significantly reduced cardiac contractility and impaired diastolic function, whereas TUDCA administration could reverse cardiac function decline. Furthermore, we observed TUDCA significantly increased the survival rate in CVB3-infected mice ( Figure 3G ). Together, these findings suggest that ER stress plays an important role in CVB3-induced cardiac damage and dysfunction in mice.
TUDCA Suppresses CVB3 Infection-Induced Cardiac CHOP Expression and Cardiomyocytes Apoptosis In Vivo
It has been suggested that cardiomyocyte apoptosis contributes to development of CVB3-induced AVMC. 31 Given ER stress could directly initiate proapoptotic signaling by activating its downstream CHOP, 12 we hypothesized CHOP-mediated proapoptotic pathways may be involved in CVB3-induced AVMC. Heart of CVB3-infected mice exhibited similar positive staining area of CVB3 VP1 and CHOP ( Figure III in the Data Supplement). Both immunohistochemical staining and Western blot analysis confirmed markedly elevated CHOP expression in heart of AVMC mice, which could be suppressed by TUDCA treatment (Figure 4A-4D) .
We further assayed CHOP-mediated proapoptotic pathways in AVMC. In agreement with previous studies, we found cardiomyocyte apoptosis in CVB3-infected mice was significantly increased by TUNEL assay ( Figure 4F ; Figure IV in the Data Supplement), as well as an enhanced expression of cleaved caspase 3 in the infected mice hearts ( Figure 4C and 4E). CHOP decreases Bcl-2 expression and leads to proapoptotic Bax activation. 32 Indeed, Bax expression was increased while Bcl-2 expression was decreased in the AVMC hearts, leading to a reduction of the Bcl-2/Bax ratio ( Figure 5) . These effects could all be blocked by TUDCA treatment (Figures 4  and 5 ).
CHOP Deficiency Reduces CVB3-Induced Cardiomyocytes Apoptosis In Vivo
To further understand the role of CHOP in CVB3-induced cardiomyocytes apoptosis, we analyzed cardiomyocytes apoptosis in CVB3-infected CHOP deficiency mice. We performed TUNEL staining to identify apoptotic cardiomyocytes and found that CHOP deficiency markedly prevented CVB3-induced cardiomyocytes apoptosis 7 days pi ( Figure 6A ; Figure V in the Data Supplement). Western blot analysis further confirmed that CHOP deficiency significantly attenuated markers of apoptosis pathway in heart, including cleaved caspase 3 ( Figure 6B and 6D) , and prevented Bcl-2 reduction and Bax induction in AVMC hearts ( Figure 6E and 6F) . Thus, these data support the notion that CHOP, a transcription factor involved in ER stress-initiated apoptotic signaling, participates in CVB3-induced cardiomyocytes apoptosis in vivo.
Ablation of CHOP Suppresses CVB3-Induced AVMC In Vivo
Encouraged by our preliminary data, the functional significance of CHOP in CVB3 infection-induced AVMC was pi. In addition, deficiency of CHOP effectively suppressed CVB3-induced serum cTnI elevation ( Figure 8A) .
We determined parameters of heart failure. Similar with previous reports, CHOP deficiency did not alter cardiac function (Table III in the Data Supplement) . 12, 33 Compared with WT CVB3-infected mice, CHOP deficiency markedly reduced ANP expression and heart weight/body weight ratio ( Figure 6B, 6C and 8B) . Echocardiography and hemodynamic analysis were further performed. As Figure 8C -8F, Tables IV and V in the Data Supplement illustrated, CHOP deficiency prevented mice from reduced ejection fraction, fractional shortening, dP/dt max, dP/dt min, and left ventricular systolic pressure, as well as increased left ventricular end diastolic pressure, indicating its protective role in CVB3-induced cardiac dysfunction. In addition, CHOP deficiency mice showed a significantly reduced mortality after infection ( Figure 8G ).
Discussion
Our study demonstrated that ER stress and its downstream activator CHOP are important factors in CVB3-induced AMVC development and cardiomyocytes apoptosis in vivo. Such evidence first came from experiment that ER stress was activated in heart of CVB3-induced AVMC mice, and was associated with enhanced cardiomyocytes apoptosis and cardiac CHOP expression. It is further supported from the results that ER stress inhibition markedly suppressed these effects, attenuated viral replication and cardiac injury, prevented cardiac dysfunction, and increased survival. We further demonstrated that genetically deficient of CHOP could suppress cardiomyocytes apoptosis, impede AVMC development and increase survival rate in CVB3-infected mice. These results indicate that inhibition of ER stress and CHOP could point to be a potential therapeutic strategy for AVMC treatment.
ER is one of the organelles that are highly susceptible to stimuli, including viral infection. 14 Viruses use ER as the site of envelope protein synthesis and viral particle assembly, 13 and some viruses develop to interfere UPR signaling for enhancement of infection and replication. 34, 35 CVB3 is a nonenveloped positive-strand RNA virus, and it requires ER in host cells for its replication. 36 Recent reports indicated that CVB3 could trigger ER stress in HeLa and HL-1 cells, 17, 18 thus it is not surprising that ER stress is evoked in CVB3-induced AVMC hearts. Indeed, our data first demonstrated that all the 3 branches of ER stress were activated in hearts of CVB3infected AVMC mice, which was consistent with previous data in HeLa and HL-1 cells. 17 To cope with ER stress condition, UPR is activated to resist perturbations and restore ER functions. 6 Despite the beneficial effect of UPR during transient ER stress, prolonged ER stress could activate CHOP, lead to cell apoptosis, and promote disease development. 7, 9, 26 Reports already documented that cardiomyocytes apoptosis occurs and contributes to development and severity of CVB3-induced AVMC. 37, 38 About the link between ER stress/CHOP signaling and apoptosis, it suggests that ER stress and its downstream activator CHOP may also be emerged in AVMC development induced by CVB3. Our observation truly confirmed this hypothesis by identifying CHOP activation accompanied with increased cardiomyocytes apoptosis in AVMC hearts.
Studies have documented that CHOP initiated proapoptotic pathways in several mechanisms, such as downregulation of the antiapoptotic protein Bcl-2, 32 and upregulation of the proapoptotic proteins Bax and Bim. 33, 39 In addition, CHOP activation leads to translocation of Bax protein to the mitochondria, 40 and finally results in activation of caspase 3. 12 Our finding indicates the reduction of Bcl-2/Bax ratio in CVB3-induced AVMC, further supporting that CHOPmediated apoptosis plays a role in AVMC, which is mainly through a mitochondria-dependent pathway. However, the precise apoptosis cascade downstream of CHOP still remains unclear and requires further investigation.
Although all of the results discussed above provided support to the hypothesis that ER stress/CHOP signaling plays a role in the pathogenesis of CVB3 infection-induced AVMC, they also raised a crucial question that whether altering ER stress/CHOP signaling could be used as a treatment strategy for CVB3-induced AVMC. TUDCA, a chemical chaperone, has been well demonstrated to be a classic ER stress inhibitor by improving ER folding capacity. 19 It has been proved to be protective in various diseases, such as diabetes mellitus, hypertension, calcification, and even cardiac dysfunction via prevention of ER stress. 11, 19, 41, 42 We also observed that TUDCA administration markedly suppressed cardiac ER stress and CHOP induction, prevented cardiomyocytes apoptosis, cardiac inflammation and injury, cardiac dysfunction, and increased survival rate in our CVB3 inoculation-induced AVMC model. This further indicates ER stress in AVMC is not merely a secondary consequence.
Recent studies showed the protective effects of CHOP deficiency in various diseases, including myocardial ischemia/reperfusion injury and pressure overload-induced cardiac dysfunction. 12, 33 CVB3 infection-induced cardiac injury and dysfunction, and caused mortality in mice, whereas these changes were significantly attenuated in CHOP-deficient mice. In addition, we showed that these protective effects were associated with reduced cardiomyocytes apoptosis in vivo, possibly via restoring Bcl-2/ Bax ratio and preventing caspase 3 activation. These findings also suggest that CHOP plays a crucial role in CVB3induced AVMC progression.
The link between ER stress and viral replication is complicated. Some reports indicate that ER stress signaling promotes certain virus replication. 43 It is interesting that TUDCA treatment or CHOP ablation also reduced CVB3 replication in vivo. This might be caused by reduced apoptosis that limits virus spreads and infects nearby cells. However, detailed mechanisms need to be explored.
This study used TUNEL to determine the apoptotic cardiomyocytes. It should be noted that TUNEL staining may not only labeled late-stage apoptotic cell, but may also label DNA undergoing necrotic cell death. 44 To sum up, the ER stress-induced CHOP-mediated pathway is involved in the pathogenesis of CVB3-induced AVMC via promoting cardiomyocytes apoptosis. Inhibition of ER stress or genetic ablation of CHOP leads to reduction of cardiomyocytes apoptosis, prevention of cardiac injury, amelioration of cardiac function, and increase of survival rate in CVB3-induced AVMC. Our findings suggest the translational potentiality of ER stress/CHOP signaling in AVMC management. 
